1. Home
  2. ACXP vs POCI Comparison

ACXP vs POCI Comparison

Compare ACXP & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

N/A

Current Price

$1.26

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

N/A

Current Price

$4.22

Market Cap

47.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACXP
POCI
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
47.8M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
ACXP
POCI
Price
$1.26
$4.22
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
★ 79.3K
50.9K
Earning Date
11-11-2026
09-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 49.41
EPS
N/A
★ N/A
Revenue
N/A
★ $31,531,765.00
Revenue This Year
N/A
$56.65
Revenue Next Year
N/A
$15.23
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 65.16
52 Week Low
$1.27
$3.55
52 Week High
$8.34
$6.15

Technical Indicators

Market Signals
Indicator
ACXP
POCI
Relative Strength Index (RSI) 37.98 42.05
Support Level N/A $4.05
Resistance Level $1.46 $4.25
Average True Range (ATR) 0.05 0.22
MACD -0.01 -0.03
Stochastic Oscillator 31.58 19.04

Price Performance

Historical Comparison
ACXP
POCI

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: